Indication
CHEK1
1 clinical trial
1 product
1 drug
Clinical trial
An Open-label, Multicenter Phase II Study to Compare the Efficacy of Carboplatin as First-line Followed by Second-line Olaparib Versus Olaparib as First-line Followed by Second-line Carboplatin in the Treatment of Patients With Castration Resistant Prostate Cancer Containing Homologous Recombination DeficiencyStatus: Recruiting, Estimated PCD: 2024-08-30
Drug
AN0025Product
Olaparib